These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17541306)

  • 1. Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy.
    Akhtar M; Ordovas K; Martin A; Higgins CB; Michaels AD
    Congest Heart Fail; 2007; 13(3):130-5. PubMed ID: 17541306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
    Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic heart failure: global left ventricular perfusion and coronary flow reserve with velocity-encoded cine MR imaging: initial results.
    Lund GK; Watzinger N; Saeed M; Reddy GP; Yang M; Araoz PA; Curatola D; Bedigian M; Higgins CB
    Radiology; 2003 Apr; 227(1):209-15. PubMed ID: 12668746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing coronary sinus blood flow in patients with coronary artery disease: a comparison of phase-contrast MR imaging with positron emission tomography.
    Koskenvuo JW; Hartiala JJ; Knuuti J; Sakuma H; Toikka JO; Komu M; Saraste M; Niemi P
    AJR Am J Roentgenol; 2001 Nov; 177(5):1161-6. PubMed ID: 11641194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry.
    Wongpraparut N; Siwamogsatham S; Thongsri T; Ngamjanyaporn P; Phrommintikul A; Jirajarus K; Tangcharoen T; Bhumimuang K; Kaewsuwanna P; Krittayaphong R; Pongakasira R; White HD
    BMC Cardiovasc Disord; 2020 Jan; 20(1):8. PubMed ID: 31918676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease.
    Zervos G; Zusman RM; Swindle LA; Alpert NM; Fischman AJ; Gewirtz H
    Coron Artery Dis; 1999 May; 10(3):185-94. PubMed ID: 10352896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus.
    Watzinger N; Lund GK; Saeed M; Reddy GP; Araoz PA; Yang M; Schwartz AB; Bedigian M; Higgins CB
    J Magn Reson Imaging; 2005 Apr; 21(4):347-53. PubMed ID: 15778950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study.
    Santagata P; Rigo F; Gherardi S; Pratali L; Drozdz J; Varga A; Picano E
    Int J Cardiol; 2005 Oct; 105(1):46-52. PubMed ID: 16207544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study.
    El-Kady T; El-Sabban K; Gabaly M; Sabry A; Abdel-Hady S
    Am J Cardiovasc Drugs; 2005; 5(4):271-8. PubMed ID: 15984909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy.
    Belardinelli R; Belardinelli L; Shryock JC
    Eur Heart J; 2001 Jul; 22(14):1205-13. PubMed ID: 11440493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
    Chen WJY; Diamant M; de Boer K; Harms HJ; Robbers LFHJ; van Rossum AC; Kramer MHH; Lammertsma AA; Knaapen P
    Cardiovasc Diabetol; 2017 May; 16(1):67. PubMed ID: 28526033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy.
    Rigo F; Gherardi S; Galderisi M; Sicari R; Picano E
    Am J Cardiol; 2007 Apr; 99(8):1154-8. PubMed ID: 17437747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve.
    Johnson NP; Gould KL
    JACC Cardiovasc Imaging; 2011 Sep; 4(9):990-8. PubMed ID: 21920337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVD.
    Quesada O; Hermel M; Suppogu N; Aldiwani H; Shufelt C; Mehta PK; Cook-Wiens G; Maughan J; Berman DS; Thomson LEJ; Handberg EM; Pepine CJ; Bairey Merz CN; Wei J
    J Am Heart Assoc; 2020 Jul; 9(13):e016305. PubMed ID: 32578481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.